Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Marcovina

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|December 1, 1995
A unique genetic and biochemical presentation of fish-eye diseaseJ A Kuivenhoven, E J van Voorst tot Voorst, H Wiebusch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and Apo(a) fragmentsV Mooser, F Tinguely, P Fontana, et al.
International Journal of Epidemiology|February 3, 1998
Biological and lifestyle factors, and lipid and lipoprotein levels among Japanese Americans in Seattle and Japanese men in JapanT Namekata, D E Moore, K Suzuki, et al.
Biochemistry|August 29, 2001
The structure of lipoprotein(a) and ligand-induced conformational changesJ W Weisel, C Nagaswami, J L Woodhead, et al.
Journal of Internal Medicine|February 20, 2007
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic toolsS M Marcovina, F Crea, J Davignon, et al.
Clinical Genetics|October 12, 2001
Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemiaH Kim, S M Marcovina, K L Edwards, et al.
Atherosclerosis|May 23, 2001
Family history as a risk factor for early onset myocardial infarction in young womenY Friedlander, P Arbogast, S M Schwartz, et al.
Journal of Medical Genetics|July 15, 2006
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European AmericansJ-P Chretien, J Coresh, Y Berthier-Schaad, et al.
Circulation|August 18, 1999
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort StudyD Périard, A Telenti, P Sudre, et al.
Biochemistry|August 26, 1997
The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surfaceW Sangrar, B R Gabel, M B Boffa, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|December 1, 1995
A unique genetic and biochemical presentation of fish-eye diseaseJ A Kuivenhoven, E J van Voorst tot Voorst, H Wiebusch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and Apo(a) fragmentsV Mooser, F Tinguely, P Fontana, et al.
International Journal of Epidemiology|February 3, 1998
Biological and lifestyle factors, and lipid and lipoprotein levels among Japanese Americans in Seattle and Japanese men in JapanT Namekata, D E Moore, K Suzuki, et al.
Biochemistry|August 29, 2001
The structure of lipoprotein(a) and ligand-induced conformational changesJ W Weisel, C Nagaswami, J L Woodhead, et al.
Journal of Internal Medicine|February 20, 2007
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic toolsS M Marcovina, F Crea, J Davignon, et al.
Clinical Genetics|October 12, 2001
Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemiaH Kim, S M Marcovina, K L Edwards, et al.
Atherosclerosis|May 23, 2001
Family history as a risk factor for early onset myocardial infarction in young womenY Friedlander, P Arbogast, S M Schwartz, et al.
Journal of Medical Genetics|July 15, 2006
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European AmericansJ-P Chretien, J Coresh, Y Berthier-Schaad, et al.
Circulation|August 18, 1999
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort StudyD Périard, A Telenti, P Sudre, et al.
Biochemistry|August 26, 1997
The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surfaceW Sangrar, B R Gabel, M B Boffa, et al.
Pageof 11